Recent Patents on Anti-Cancer Drug Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 39.9% | 0.635 | Q2 | 69.5% |
| 2024 | 4.1 | Q1 | 77.9% | 0.667 | Q2 | 72.0% |
| 2023 | 2.5 | Q3 | 50.3% | 0.540 | Q2 | 67.4% |
| 2022 | 2.8 | Q3 | 49.1% | 0.558 | Q2 | 69.8% |
| 2021 | 3.0 | Q3 | 50.9% | 0.629 | Q2 | 74.3% |
| 2020 | — | — | 0.710 | Q2 | 76.5% | |
| 2019 | — | — | 0.603 | Q2 | 72.8% | |
| 2018 | — | — | 0.529 | Q2 | 67.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2212-3970
ISSN
1574-8928
country
AEcoverage
2006-2026